Inven2
Osloinven2.com
Overview
Inven2 is a Norwegian technology transfer office that commercializes research from the University of Oslo and Oslo University Hospital by creating and investing in spin-off companies primarily in the healthcare and life sciences sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| OstomyCure AS | Jul 2026 | Early Funding | Co-investor |
| Tribune Therapeutics | Mar 2025 | Series A | Co-investor |
| Tribune Therapeutics | Jun 2021 | Seed | Co-investor |
| Serca Pharmaceuticals | Jul 2019 | VC Round | Co-investor |
| Respinor AS | Sep 2016 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
